Robert Kilkuskie

Direttore/Membro del Consiglio presso Michigan High Throughput Screening Center

Commercial Services

Profilo

Robert Kilkuskie currently works at Michigan High Throughput Screening Center, as Executive Director from 2009 and National Institute of Health Policy, as Principal.

Posizioni attive di Robert Kilkuskie

Società	Posizione	Inizio
Michigan High Throughput Screening Center Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties.	Direttore/Membro del Consiglio	-
National Institute of Health Policy	Corporate Officer/Principal	30/04/2010

Tutte le posizioni attive di Robert Kilkuskie

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robert Kilkuskie

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
National Institute of Health Policy
Michigan High Throughput Screening Center Michigan High Throughput Screening Center Miscellaneous Commercial ServicesCommercial Services Michigan High Throughput Screening Center develops screening technologies for drug discovery. It offers services to academic institutions, biotechnology & pharmaceutical companies, and government laboratories. The firm is a not-for-profit contract research organization. Its scientists has extensive experience in drug discovery research and have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology. It also has an extremely diverse library containing 100,000 drug able compounds and requires no licensing fees or royalties.	Commercial Services